MAPK3 and cervical carcinoma: Jiang et al. revealed that the inhibition of ALOX12B could restrain cervical cancer cell proliferation and growth through suppressing the PI3K/ERK1 pathway, suggesting that it can be taken as a good biomarker to provide new therapeutic strategies for cervical cancer patients (Jiang et al., 2020).